• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国 2 型糖尿病患者强化胰岛素治疗时胰岛素剂量分析。

Analysis of insulin doses of Chinese type 2 diabetic patients with intensive insulin treatment.

机构信息

Endocrinology and Metabolism Department, Peking University People's Hospital, Beijing, China.

出版信息

PLoS One. 2012;7(6):e38962. doi: 10.1371/journal.pone.0038962. Epub 2012 Jun 18.

DOI:10.1371/journal.pone.0038962
PMID:22720003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3377710/
Abstract

BACKGROUND

To investigate the daily insulin doses and the ratio of basal insulin to total daily insulin in Chinese type 2 diabetic patients who received basal bolus insulin therapy.

METHODOLOGY/PRINCIPAL FINDINGS: Totally 2480 patients prescribed with pre-meal bolus insulin and bedtime basal insulin were included. The mean daily insulin doses was 38.22 ± 14.92 IU/day, the mean daily insulin doses per weight was 0.58 ± 0.22 IU/kg, the mean bolus insulin dose was 0.44 ± 0.17 IU/kg and the mean basal insulin dose was 0.13 ± 0.08 IU/kg. The mean basal/total daily insulin ratio (BD/TDD) was 0.23 ± 0.08. In most patients (47.94%), the BD/TDD was between 0.20 and 0.30. Diabetic duration, BMI, HbA1c, fasting and postprandial blood glucose level were positively associated with daily insulin dose, while age was negatively associated with daily insulin dose. Diabetic duration, BMI, HbA1c, fasting blood glucose level, and using metformin were positively associated with BD/TDD ratio, while age, postprandial C peptide, postprandial blood glucose level and CRE level were negatively associated with BD/TDD ratio.

CONCLUSIONS/SIGNIFICANCE: The daily insulin doses of intensive treatment in Chinese type 2 diabetic patients was 38.22 IU/day, the mean daily insulin doses per weight was 0.58 IU/kg, mean BD/TDD ratio was 0.23.

摘要

背景

研究接受基础-餐时胰岛素方案治疗的中国 2 型糖尿病患者的每日胰岛素剂量和基础胰岛素与每日总胰岛素剂量的比例。

方法/主要发现:共纳入 2480 例接受餐前餐时胰岛素和睡前基础胰岛素治疗的患者。平均每日胰岛素剂量为 38.22±14.92IU/天,平均每公斤体重的胰岛素剂量为 0.58±0.22IU/kg,平均餐时胰岛素剂量为 0.44±0.17IU/kg,平均基础胰岛素剂量为 0.13±0.08IU/kg。基础胰岛素与每日总胰岛素剂量的比例(BD/TDD)的平均值为 0.23±0.08。在大多数患者(47.94%)中,BD/TDD 处于 0.20 至 0.30 之间。糖尿病病程、BMI、HbA1c、空腹和餐后血糖水平与胰岛素剂量呈正相关,而年龄与胰岛素剂量呈负相关。糖尿病病程、BMI、HbA1c、空腹血糖水平和使用二甲双胍与 BD/TDD 比值呈正相关,而年龄、餐后 C 肽、餐后血糖水平和 CRE 水平与 BD/TDD 比值呈负相关。

结论/意义:中国 2 型糖尿病患者强化治疗的每日胰岛素剂量为 38.22IU/天,平均每公斤体重的胰岛素剂量为 0.58IU/kg,平均 BD/TDD 比值为 0.23。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b0d/3377710/ab104c27c39c/pone.0038962.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b0d/3377710/ab104c27c39c/pone.0038962.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b0d/3377710/ab104c27c39c/pone.0038962.g001.jpg

相似文献

1
Analysis of insulin doses of Chinese type 2 diabetic patients with intensive insulin treatment.中国 2 型糖尿病患者强化胰岛素治疗时胰岛素剂量分析。
PLoS One. 2012;7(6):e38962. doi: 10.1371/journal.pone.0038962. Epub 2012 Jun 18.
2
Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetes.2 型糖尿病患者胰岛素泵治疗的胰岛素需求特征及相关因素。
Sci China Life Sci. 2019 Nov;62(11):1506-1513. doi: 10.1007/s11427-018-9530-3. Epub 2019 May 22.
3
Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.在2型糖尿病患者中,使用基础胰岛素类似物的餐时50/50基础胰岛素与餐时胰岛素类似物混合制剂,并联合二甲双胍,以实现糖化血红蛋白(HbA1c)目标值以及餐前和餐后血糖水平:一项多国、24周、随机、开放标签、平行组对照研究。
Clin Ther. 2007 Nov;29(11):2349-64. doi: 10.1016/j.clinthera.2007.11.016.
4
Insulin requirement profiles of patients with type 2 diabetes after achieving stabilized glycemic control with short-term continuous subcutaneous insulin infusion.短期持续皮下胰岛素输注使 2 型糖尿病患者血糖控制稳定后胰岛素需求特征。
Diabetes Technol Ther. 2010 Apr;12(4):271-81. doi: 10.1089/dia.2009.0131.
5
Insulin requirement profiles in Japanese hospitalized subjects with type 2 diabetes treated with basal-bolus insulin therapy.接受基础-餐时胰岛素治疗的日本住院2型糖尿病患者的胰岛素需求情况
Endocr J. 2015;62(2):209-16. doi: 10.1507/endocrj.EJ14-0487. Epub 2014 Nov 11.
6
Basal insulin requirement in patients with type 1 diabetes depends on the age and body mass index.1 型糖尿病患者的基础胰岛素需求量取决于年龄和体重指数。
J Diabetes Investig. 2022 Feb;13(2):292-298. doi: 10.1111/jdi.13547. Epub 2021 May 3.
7
Carbohydrate-to-insulin ratio is estimated from 300-400 divided by total daily insulin dose in type 1 diabetes patients who use the insulin pump.在使用胰岛素泵的 1 型糖尿病患者中,碳水化合物与胰岛素的比例是根据 300-400 除以总日胰岛素剂量来估计的。
Diabetes Technol Ther. 2012 Nov;14(11):1077-80. doi: 10.1089/dia.2012.0109.
8
Effects of basal insulin analog and metformin on glycaemia control and weight as risk factors for endothelial dysfunction.基础胰岛素类似物和二甲双胍对血糖控制及体重的影响作为内皮功能障碍的危险因素
Bosn J Basic Med Sci. 2008 Nov;8(4):309-12. doi: 10.17305/bjbms.2008.2882.
9
Investigation of the insulin dose and characteristics of continuous subcutaneous insulin infusion in Chinese people with type 2 diabetes.中国人 2 型糖尿病患者胰岛素剂量和持续皮下胰岛素输注特点的调查。
Diabetes Technol Ther. 2011 Nov;13(11):1135-8. doi: 10.1089/dia.2011.0109. Epub 2011 Sep 15.
10
A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes.一项为期52周的多国、开放标签、平行组、非劣效性、达标治疗试验,在2型糖尿病患者中,比较德谷胰岛素与甘精胰岛素在基础-餐时胰岛素方案中联合门冬胰岛素的疗效。
Clin Ther. 2008 Nov;30(11):1976-87. doi: 10.1016/j.clinthera.2008.11.001.

引用本文的文献

1
Fasting plasma glucose level-based formula for estimating starting daily dose in basal-bolus insulin therapy.基于空腹血糖的基础-餐时胰岛素治疗起始日剂量估算公式。
Sci Rep. 2023 Jan 19;13(1):1032. doi: 10.1038/s41598-023-28138-6.
2
A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes.1型糖尿病成人持续皮下胰岛素输注(CSII)胰岛素给药公式综述
Curr Diab Rep. 2016 Sep;16(9):83. doi: 10.1007/s11892-016-0772-0.
3
Attributes Influencing Insulin Pen Preference Among Caregivers and Patients With Diabetes Who Require Greater Than 20 Units of Mealtime Insulin.

本文引用的文献

1
Comparison of insulin detemir and insulin glargine using a basal-bolus regimen in a randomized, controlled clinical study in patients with type 2 diabetes.在一项针对2型糖尿病患者的随机对照临床研究中,使用基础-餐时方案比较地特胰岛素和甘精胰岛素。
Diabetes Metab Res Rev. 2009 Sep;25(6):542-8. doi: 10.1002/dmrr.989.
2
A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes.一项为期52周的多国、开放标签、平行组、非劣效性、达标治疗试验,在2型糖尿病患者中,比较德谷胰岛素与甘精胰岛素在基础-餐时胰岛素方案中联合门冬胰岛素的疗效。
Clin Ther. 2008 Nov;30(11):1976-87. doi: 10.1016/j.clinthera.2008.11.001.
3
影响需要超过20单位餐时胰岛素的糖尿病患者及其照顾者胰岛素笔偏好的因素。
J Diabetes Sci Technol. 2016 Jun 28;10(4):923-31. doi: 10.1177/1932296816633232. Print 2016 Jul.
4
Comparison of continuous subcutaneous insulin infusion and insulin glargine-based multiple daily insulin aspart injections with preferential adjustment of basal insulin in patients with type 2 diabetes.2型糖尿病患者中持续皮下胰岛素输注与基于甘精胰岛素的多次门冬胰岛素注射并优先调整基础胰岛素的比较。
Exp Ther Med. 2014 Oct;8(4):1191-1196. doi: 10.3892/etm.2014.1866. Epub 2014 Jul 29.
5
Determinants of glycemic control among insulin treated diabetic patients in Southwest Ethiopia: hospital based cross sectional study.在埃塞俄比亚西南部,接受胰岛素治疗的糖尿病患者血糖控制的决定因素:一项基于医院的横断面研究。
PLoS One. 2013 Apr 19;8(4):e61759. doi: 10.1371/journal.pone.0061759. Print 2013.
Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes.德谷胰岛素加门冬胰岛素与中性鱼精蛋白锌胰岛素加正规胰岛素用于2型糖尿病内科患者的住院胰岛素治疗方案比较
J Clin Endocrinol Metab. 2009 Feb;94(2):564-9. doi: 10.1210/jc.2008-1441. Epub 2008 Nov 18.
4
Prospective randomized study for optimal insulin therapy in type 2 diabetic patients with secondary failure.2型糖尿病继发失效患者最佳胰岛素治疗的前瞻性随机研究。
Cardiovasc Diabetol. 2008 May 29;7:16. doi: 10.1186/1475-2840-7-16.
5
Comparison of twice-daily injections of biphasic insulin lispro and basal-bolus therapy: glycaemic control and quality-of-life of insulin-naïve type 2 diabetic patients.赖脯双相胰岛素每日两次注射与基础-餐时疗法的比较:初治2型糖尿病患者的血糖控制及生活质量
Diabetes Obes Metab. 2008 Dec;10(12):1261-5. doi: 10.1111/j.1463-1326.2008.00897.x. Epub 2008 May 20.
6
Effects of changes in basal/total daily insulin ratio in type 2 diabetes patients on intensive insulin therapy including insulin glargine (JUN-LAN Study 6).2型糖尿病患者基础/每日总胰岛素比例变化对包括甘精胰岛素在内的强化胰岛素治疗的影响(JUN-LAN研究6)
Diabetes Res Clin Pract. 2008 Aug;81(2):e1-3. doi: 10.1016/j.diabres.2008.03.021. Epub 2008 May 16.
7
Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents: prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy.在先前接受甘精胰岛素联合口服药物治疗的2型糖尿病患者中推进胰岛素治疗:餐时预混胰岛素(赖脯胰岛素鱼精蛋白混悬液/赖脯胰岛素)与基础/餐时胰岛素(甘精胰岛素/赖脯胰岛素)治疗对比
Diabetes Care. 2008 Jan;31(1):20-5. doi: 10.2337/dc07-1122. Epub 2007 Oct 12.
8
Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial).基础-餐时胰岛素治疗在2型糖尿病患者住院管理中的随机研究(RABBIT 2试验)
Diabetes Care. 2007 Sep;30(9):2181-6. doi: 10.2337/dc07-0295. Epub 2007 May 18.
9
Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.2型糖尿病高血糖管理:治疗起始与调整的共识算法:美国糖尿病协会和欧洲糖尿病研究协会的共识声明
Diabetes Care. 2006 Aug;29(8):1963-72. doi: 10.2337/dc06-9912.
10
Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.2型糖尿病高血糖管理:治疗起始与调整的共识算法。美国糖尿病协会和欧洲糖尿病研究协会的共识声明。
Diabetologia. 2006 Aug;49(8):1711-21. doi: 10.1007/s00125-006-0316-2.